Intervention

Sham rTMS

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 25 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials25
Recruiting4
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

25 shown
TMS for Cognitive Decline in Aging and Preclinical ADNCT06956300 · 2025-04-07
RECRUITING
Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of DepressionNCT06363981 · 2024-05-20
RECRUITING
Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for PsychosisNCT06542640 · 2024-01-01
RECRUITING
Transcranial Magnetic Stimulation Treatment for Alzheimer's DiseaseNCT06538311 · 2023-05-01
RECRUITING
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)NCT07772349 · 2026-10-01
NOT_YET_RECRUITING
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant SchizophreniaNCT07445620 · 2026-09-15
NOT_YET_RECRUITING
HF-rTMS Primed Balance Training on Corticomotor Excitability, Balance, and Gait in Parkinson'sNCT07653256 · 2026-07-01
NOT_YET_RECRUITING
rTMS and Olfactory Training for Parkinson's DiseaseNCT07666477 · 2026-01-02
COMPLETED
iTBS in MCI and Mild ADNCT06670820 · 2024-10-31
NOT_YET_RECRUITING
Clinical, Cognitive and Neural Effects of Potentiation of ECT by rTMS in Treatment-Resistant DepressionNCT06391723 · 2024-06-01
UNKNOWN
rTMS for the Treatment of Neuropathic Pain in Diabetic PatientsNCT05792072 · 2023-05-02
UNKNOWN
Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in DepressionNCT05224063 · 2023-01-01
COMPLETED
Personalized Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive EpisodeNCT05465928 · 2022-08-02
COMPLETED
Noninvasive Brain Stimulation for pADNCT05468268 · 2022-07-04
UNKNOWN
Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in SchizophreniaNCT07190352 · 2021-10-04
COMPLETED
Network-based rTMS in Alzheimer's DiseaseNCT04263194 · 2019-03-21
UNKNOWN
Combining rTMS With Varenicline to Prevent Smoking Lapse in SchizophreniaNCT03497299 · 2018-07-01
WITHDRAWN
The Study of Effectiveness of rTMS on Rumination and Anhedonia in Patients With Major Depressive DisorderNCT03468686 · 2016-12-21
COMPLETED
rTMS for the Treatment of Freezing of Gait in Parkinson's DiseaseNCT03219892 · 2016-12-01
COMPLETED
High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Major DepressionNCT02702154 · 2016-02-01
UNKNOWN
Exercise and Transcranial Magnetic Stimulation: Increasing Brain Plasticity in Parkinson's DiseaseNCT02741765 · 2015-11-01
COMPLETED
A Study of rTMS for Cognitive Deficits in Chronic Patients With SchizophreniaNCT03273439 · 2012-07-01
COMPLETED
50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's DiseaseNCT00977184 · 2009-09-01
COMPLETED
Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread PainNCT00524420 · 2008-02-01
COMPLETED
TMS in the Treatment of the Sequelae of Closed Brain InjuryNCT00531258 · 2008-01-01
COMPLETED

Common conditions

Leading sponsors

Trial status mix

COMPLETED11
UNKNOWN5
NOT_YET_RECRUITING4
RECRUITING4
WITHDRAWN1

Phase mix

NA21
PHASE23
EARLY_PHASE11
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.